Phase 4 Alzheimer's Disease Trial, By Invitation NCT00950430 Sponsor: Mayo Clinic Condition: Alzheimer's Disease
Back to Alzheimers Disease

Phase 4 Alzheimer's Disease Trial, By Invitation

NCT00950430
By Invitation Phase 4

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People between the ages of 30 and 100.
  • People who have already completed, or are planned to undergo, neurological assessments through the Mayo Clinic Study of Aging, the Mayo Alzheimer's Disease Research Center (ADRC), or the Mayo neurodegenerative disease clinics.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who are unable to lie still without moving for 10 minutes.
  • Women who are pregnant, or who are unable to stop breastfeeding for 24 hours before the scan.
  • People who experience severe claustrophobia (fear of enclosed spaces) that would prevent them from tolerating the scans.
  • People with certain metal-related safety concerns, such as metallic objects in the body or a pacemaker, that would make an MRI scan unsafe (confirm with trial site for a full list of what applies).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 12 August 2026
Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
By Invitation
Phase
Phase 4
Sponsor
Registry
ClinicalTrials.gov
Start date
1 April 2008
Est. completion
1 June 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

To understand the predictive ability of PiB PET imaging for neurodegenerative diseases.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 12 August 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov